These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 15559532

  • 1. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
    Sólyom J, Eckhardt G, Török D.
    Orv Hetil; 2004 Oct 03; 145(40):2051-6. PubMed ID: 15559532
    [Abstract] [Full Text] [Related]

  • 2. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
    Török D, Eckhardt G, Sólyom J.
    Eur J Pediatr; 2003 Dec 03; 162(12):844-9. PubMed ID: 14648216
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY, Lee CT, Tung YC, Chien YH, Hwu WL, Tsai WY.
    J Formos Med Assoc; 2018 Feb 03; 117(2):126-131. PubMed ID: 28392195
    [Abstract] [Full Text] [Related]

  • 4. [Screening for congenital adrenal hyperplasia in Hungary].
    Sólyom J.
    Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047
    [Abstract] [Full Text] [Related]

  • 5. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
    Tonetto-Fernandes V, Lemos-Marini SH, Kuperman H, Ribeiro-Neto LM, Verreschi IT, Kater CE.
    J Clin Endocrinol Metab; 2006 Jun 10; 91(6):2179-84. PubMed ID: 16551734
    [Abstract] [Full Text] [Related]

  • 6. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.
    Escobar-Morreale HF, Sanchón R, San Millán JL.
    J Clin Endocrinol Metab; 2008 Feb 10; 93(2):527-33. PubMed ID: 18000084
    [Abstract] [Full Text] [Related]

  • 7. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug 10; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 8. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N, Riepe FG, Peter M, Sander S, Steuerwald U, Korsch E, Krull F, Müller HL, Heger S, Brack C, Sander J.
    Horm Res Paediatr; 2012 Aug 10; 77(3):195-9. PubMed ID: 22508345
    [Abstract] [Full Text] [Related]

  • 9. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 10. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM, Abad LR, Cua SC, Domingo CF.
    Southeast Asian J Trop Med Public Health; 2003 Jan 17; 34 Suppl 3():174-8. PubMed ID: 15906729
    [Abstract] [Full Text] [Related]

  • 11. A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing.
    Gong LF, Gao X, Yang N, Zhao JQ, Yang HH, Kong YY.
    J Pediatr Endocrinol Metab; 2019 Mar 26; 32(3):253-258. PubMed ID: 30817302
    [Abstract] [Full Text] [Related]

  • 12. Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia.
    Votava F, Török D, Kovács J, Möslinger D, Baumgartner-Parzer SM, Sólyom J, Pribilincová Z, Battelino T, Lebl J, Frisch H, Waldhauser F, Middle European Society for Paediatric Endocrinology -- Congenital Adrenal Hyperplasia (MESPE-CAH) Study Group.
    Eur J Endocrinol; 2005 Jun 26; 152(6):869-74. PubMed ID: 15941926
    [Abstract] [Full Text] [Related]

  • 13. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb 26; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 14. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS, Rassi TO, Araujo RF, Pezzuti IL, Rodrigues AS, Bachega TASS, Silva IN.
    J Pediatr Endocrinol Metab; 2019 May 27; 32(5):499-504. PubMed ID: 31028712
    [Abstract] [Full Text] [Related]

  • 15. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC, Carvajal F, Frómeta A, Arteaga AL, Castells EM, Espinosa T, Coto R, Pérez PL, Tejeda Y, Del Río L, Segura MT, Almenares P, Robaina R, Fernández JL.
    Clin Chim Acta; 2013 Jun 05; 421():73-8. PubMed ID: 23481450
    [Abstract] [Full Text] [Related]

  • 16. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J, Hughes IA.
    Arch Dis Child; 1989 Mar 05; 64(3):338-42. PubMed ID: 2705794
    [Abstract] [Full Text] [Related]

  • 17. Raised 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Iqbal S, Khan AH.
    J Coll Physicians Surg Pak; 2013 May 05; 23(5):373-4. PubMed ID: 23673184
    [Abstract] [Full Text] [Related]

  • 18. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW.
    Ann Clin Biochem; 2014 Jul 05; 51(Pt 4):424-40. PubMed ID: 24711560
    [Abstract] [Full Text] [Related]

  • 19. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P, Szabó P, Marginean O, Bereczki C, Karg E.
    Horm Res Paediatr; 2015 Jul 05; 84(5):311-8. PubMed ID: 26397944
    [Abstract] [Full Text] [Related]

  • 20. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
    Silveira EL, Elnecave RH, dos Santos EP, Moura V, Pinto EM, van der Linden Nader I, Mendonca BB, Bachega TA.
    Clin Genet; 2009 Dec 05; 76(6):503-10. PubMed ID: 19930153
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.